Activation of NLRP3 inflammasomes is highly dependent on ASC recruitment of free procaspase-1 and NLRP3 activation; therefore, targeted inhibition of ASC could also be a therapeutic strategy for stroke. Here, NLRP3 is linked to stroke disorder.